Multidrug-resistant cutaneous tuberculosis: Response to therapy

Pediatric Dermatology

Volumn 20, Issue 6, 2003, Pages 545-547

  Nanda, Soni ^a   Rajpal, Monika ^a   Reddy, B S N ^a  

^a NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; CASE REPORT; HUMAN; LETTER; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SKIN TUBERCULOSIS; TREATMENT OUTCOME; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

AMIKACIN; ANTITUBERCULAR AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LEG ULCER; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, CUTANEOUS;

EID: 0347694851     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2003.20622.x     Document Type: Letter

References (5)

1. Ramesh V, Murlidhar S, Kumar J, et al. Isolation of drug-resistant tubercle bacilli in cutaneous tuberculosis. Pediatr Dermatol 2001;18:393-395.
2. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-1374.
3. Harkin TJ, Harris HW. Treatment of multidrug-resistant tuberculosis. In: Rom WN, Garay SM, eds. Tuberculosis, 1st ed. New York: Little Brown, 1995:843-850.
4. Iseman MD. Management of multidrug-resistant tuberculosis. Chemotherapy 1999;45(suppl 2):3-11.
5. Crofton J, Chaulet P, Mahet D. Guidelines for the management of drug-resistant TB. Geneva, Switzerland: Global Tuberculosis Programme, WHO, 1997.